188 related articles for article (PubMed ID: 33845242)
1. Establishment of an induced pluripotent stem cell line (CSUi003-A) from fibroblasts of a healthy elderly individual.
Zhao H; Wang L; Wu J; Ren J; Chen Q; Luo H; Zuo X; Tang Y
Stem Cell Res; 2021 May; 53():102326. PubMed ID: 33845242
[TBL] [Abstract][Full Text] [Related]
2. An induced pluripotent stem cell line (CSUi004-A) from skin fibroblasts of a healthy individual.
Wang L; Zhao H; Wu J; Ren J; Luo H; Zuo X; Chen Q; Tang Y
Stem Cell Res; 2021 May; 53():102336. PubMed ID: 33865102
[TBL] [Abstract][Full Text] [Related]
3. Derivation and characterization of induced pluripotent stem cells from equine fibroblasts.
Breton A; Sharma R; Diaz AC; Parham AG; Graham A; Neil C; Whitelaw CB; Milne E; Donadeu FX
Stem Cells Dev; 2013 Feb; 22(4):611-21. PubMed ID: 22897112
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
[TBL] [Abstract][Full Text] [Related]
5. Establishment of two induced pluripotent stem cell line from healthy elderly (IPTi005-A and IPTi007-A).
Zhang L; Ren Q; Liu G; Wu R; Meng S; Xiahou K; Jiang N; Zhang Y; Zhou W
Stem Cell Res; 2020 May; 45():101808. PubMed ID: 32402716
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
[TBL] [Abstract][Full Text] [Related]
7. Generation of integration-free human induced pluripotent stem cells from a patient with sporadic Parkinson's disease.
Lee Y; Jeong D; Ham S; Son J; Ko K
Stem Cell Res; 2024 Jun; 77():103416. PubMed ID: 38615589
[TBL] [Abstract][Full Text] [Related]
8. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
9. Generation and characterisation of a human induced pluripotent stem cell line, NIMHi007-A, from peripheral blood mononuclear cells derived from an adult healthy female.
Nimonkar MM; Arunachal G; Dash SS; Kandy SK; Raghavendra K; Chetan GK; Mehta B; Markandeya YS
Stem Cell Res; 2023 Aug; 70():103130. PubMed ID: 37269666
[TBL] [Abstract][Full Text] [Related]
10. Generation of induced pluripotent stem cell line NIMHi010-A from dermal fibroblast cells of a healthy individual.
Dash SS; Arunachal G; Nimonkar MM; Vengalil S; Nashi S; Chetan GK; Boddu VK; Nalini A; Markandeya YS
Stem Cell Res; 2024 Apr; 76():103355. PubMed ID: 38412659
[TBL] [Abstract][Full Text] [Related]
11. Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome.
Mou X; Wu Y; Cao H; Meng Q; Wang Q; Sun C; Hu S; Ma Y; Zhang H
Stem Cell Res Ther; 2012 Apr; 3(2):14. PubMed ID: 22512921
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming of a human induced pluripotent stem cell line from one 48-year-old healthy male donor.
Guo R; Mu W; Liu X; Zhang J; Liu B; Du X; He J; Ma J; Cui H
Stem Cell Res; 2021 May; 53():102339. PubMed ID: 33892291
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of iPS cell line (CTGUi001-A) from skin fibroblasts of a patient with Fabry disease.
Qin Y; Zhan JQ; Ma CJ; Cao CY; Zhang Y; Min YT; Lv YF
Stem Cell Res; 2023 Jun; 69():103063. PubMed ID: 36917862
[TBL] [Abstract][Full Text] [Related]
14. Generation of melanocytes from induced pluripotent stem cells.
Yang R; Jiang M; Kumar SM; Xu T; Wang F; Xiang L; Xu X
J Invest Dermatol; 2011 Dec; 131(12):2458-66. PubMed ID: 21833016
[TBL] [Abstract][Full Text] [Related]
15. Establishment of PLAFMCi004-A induced pluripotent stem cells derived from PBMCs from a healthy individual.
Shang S; Chen K; Cai G; Bai X; Chen X; Li Q
Stem Cell Res; 2021 May; 53():102316. PubMed ID: 33878710
[TBL] [Abstract][Full Text] [Related]
16. Generation of a Crigler-Najjar Syndrome Type I patient-derived induced pluripotent stem cell line CNS705 (HHUUKDi005-A).
Graffmann N; Martins S; Ljubikj T; Matte JC; Bohndorf M; Wruck W; Adjaye J
Stem Cell Res; 2021 Mar; 51():102167. PubMed ID: 33485181
[TBL] [Abstract][Full Text] [Related]
17. Establishment of an induced pluripotent stem cell line (ZZUSAHi002-A) derived from peripheral blood mononuclear cells of a healthy individual.
Liu S; Niu S; Li Y; Xiong H; Li Y; Jian L; Zhang L
Stem Cell Res; 2020 Oct; 48():101966. PubMed ID: 32911326
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of induced pluripotent stem cell line IITGi001-A derived from adult human primary dermal fibroblasts.
Raina K; Joshi G; Modak K; Premkumar C; Priyanka S; Rajesh P; Velayudhan SR; Thummer RP
Stem Cell Res; 2023 Sep; 71():103159. PubMed ID: 37392703
[TBL] [Abstract][Full Text] [Related]
19. Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations.
Mori E; Fujikura J; Noguchi M; Nakao K; Matsubara M; Sone M; Taura D; Kusakabe T; Ebihara K; Tanaka T; Hosoda K; Takahashi K; Asaka I; Inagaki N; Nakao K
Metabolism; 2016 Apr; 65(4):543-56. PubMed ID: 26975546
[TBL] [Abstract][Full Text] [Related]
20. Establishment of TUSMi009-A, an induced pluripotent stem cell (iPSC) line from a 24-year-old Chinese Han patient with gliocytoma.
Chen K; Zhuang Z; Wang Q; Li K; Xu S; Liu M; Zhang K; Wei L; Zhang Y; Lian H; Zhang B; Zhong C
Stem Cell Res; 2021 Oct; 56():102546. PubMed ID: 34587579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
